STANFORD UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-11-11

Employees: 10K

Market Cap: -

Website: http://www.stanford.edu

Clinical Trials

Impact of C-arm CT in Patients With HCC Undergoing TACE: Optimal Imaging Guidance

Not Applicable

Completed

Conditions: Carcinoma, Hepatocellular

Interventions: Device: DSA only
Device: C-arm CT + DSA as needed

First Posted Date: 2009-06-23

Last Posted Date: 2016-04-04

Lead Sponsor: Stanford University

Target Recruit Count: 84

Registration Number: NCT00926536

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa

Completed

Conditions: Epidermolysis Bullosa Dystrophica

First Posted Date: 2009-05-19

Last Posted Date: 2014-05-16

Lead Sponsor: Stanford University

Target Recruit Count: 13

Registration Number: NCT00904163

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Study of T3 for the Treatment of Fibromyalgia

Not Applicable

Completed

Conditions: Fibromyalgia

Interventions: Drug: T3

First Posted Date: 2009-05-19

Last Posted Date: 2017-07-14

Lead Sponsor: Stanford University

Target Recruit Count: 51

Registration Number: NCT00903877

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG

Phase 2

Completed

Conditions: Transplantation, Autologous
Multiple Myeloma
Blood and Marrow Transplant (BMT)
Transplantation, Homologous

Interventions: Procedure: Autologous peripheral blood stem cells (auto-PBSC) transplantation
Procedure: Allogeneic peripheral blood stem cells (allo-PBSC) transplantation
Drug: Filgrastim
Drug: Cyclophosphamide
Drug: Melphalan
Drug: Cyclosporine
Radiation: Total lymphoid irradiation
Biological: Rabbit anti-thymocyte globulin
Drug: Mycophenolate Mofetil 250mg
Drug: Solumedrol
Drug: Diphenhydramine
Drug: Acetaminophen
Drug: Hydrocortisone

First Posted Date: 2009-05-12

Last Posted Date: 2017-10-20

Lead Sponsor: Stanford University

Target Recruit Count: 9

Registration Number: NCT00899847

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Early Childhood Prevention of Childhood Overweight

Phase 3

Completed

Conditions: Overweight

Interventions: Behavioral: 5-keys counseling
Behavioral: Lifestyle counseling

First Posted Date: 2009-05-11

Last Posted Date: 2011-07-25

Lead Sponsor: Stanford University

Target Recruit Count: 100

Registration Number: NCT00896545

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC)

Phase 2

Completed

Conditions: Stage II Lymphoepithelioma of the Nasopharynx
Stage III Lymphoepithelioma of the Nasopharynx
Stage III Squamous Cell Carcinoma of the Nasopharynx
Stage IV Lymphoepithelioma of the Nasopharynx
Stage IV Squamous Cell Carcinoma of the Nasopharynx
Stage II Squamous Cell Carcinoma of the Nasopharynx

Interventions: Drug: docetaxel
Drug: cisplatin
Drug: carboplatin
Drug: fluorouracil
Radiation: 3-dimensional conformal radiation therapy
Radiation: intensity-modulated radiation therapy

First Posted Date: 2009-05-11

Last Posted Date: 2021-04-06

Lead Sponsor: Stanford University

Target Recruit Count: 26

Registration Number: NCT00896181

Locations: 🇺🇸
Stanford University Hospitals and Clinics, Stanford, California, United States

Functional MRI Before and After Treatment for Depression

Not Applicable

Terminated

Conditions: Depressive Disorder
Depression
Mood Disorders

Interventions: Drug: Citalopram

First Posted Date: 2009-05-11

Last Posted Date: 2017-10-13

Lead Sponsor: Stanford University

Target Recruit Count: 31

Registration Number: NCT00896441

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Intellectual Impairment in Women With Breast Cancer

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Cognitive Rehabilitation
Behavioral: Active Neurofeedback Training
Behavioral: Neurofeedback Training (placebo / Sham)

First Posted Date: 2009-05-11

Last Posted Date: 2019-05-01

Lead Sponsor: Stanford University

Target Recruit Count: 50

Registration Number: NCT00896324

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

Phase 2

Completed

Conditions: Lymphoma, T-Cell, Cutaneous
Cutaneous T-cell Lymphoma
Mycoses
Sezary Syndrome
Bone Marrow Transplant Failure
Lymphoma, Non-Hodgkin

Interventions: Drug: anti-thymocyte globulin
Drug: cyclosporine
Radiation: Lymphoid radiation

First Posted Date: 2009-05-11

Last Posted Date: 2023-05-11

Lead Sponsor: Stanford University

Target Recruit Count: 38

Registration Number: NCT00896493

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Phase 1-2 of Azacitidine + Lenalidomide for Previously Untreated Elderly Patients With Acute Myeloid Leukemia (AML)

Phase 1

Completed

Conditions: Acute Myeloid Leukemia (AML)
Adult Acute Myeloblastic Leukemia

Interventions: Drug: Lenalidomide
Drug: Azacitidine

First Posted Date: 2009-04-30

Last Posted Date: 2018-06-18

Lead Sponsor: Stanford University

Target Recruit Count: 45

Registration Number: NCT00890929

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy